Regulation of Akt and glycogen synthase kinase-3β phosphorylation by sodium valproate and lithium

Neuropharmacology

Volumn 43, Issue 7, 2002, Pages 1158-1164

  De Sarno, Patrizia ^a   Li, Xiaohua ^a   Jope, Richard S ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

Akt; Bipolar disorder; GSK3 ; Histone deacetylase inhibitor; Lithium; Valproate

Indexed keywords

2 MORPHOLINO 8 PHENYLCHROMONE; BUTYRIC ACID; GLYCOGEN SYNTHASE KINASE 3BETA; HISTONE DEACETYLASE INHIBITOR; LITHIUM; PROTEIN KINASE B; SERINE; TRICHOSTATIN A; VALPROIC ACID;

ANIMAL EXPERIMENT; ARTICLE; BIPOLAR DISORDER; CELL LINE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; MALE; MOOD DISORDER; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SIGNAL TRANSDUCTION;

EID: 0036909443     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(02)00215-0     Document Type: Article

References (24)

1. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO Journal. 15:1996;6541-6551.
2. Bhat R.V., Shanley J., Correll M.P., Fieles W.E., Keith R.A., Scott C.W., Lee C.M. Regulation and localization of tyrosine216 phosphorylation of glycogen synthase kinase-3β in cellular and animal models of neuronal degeneration. Proceedings of the National Academy of Sciences of the USA. 97:2000;11074-11079.
3. Bijur G.N., De Sarno P., Jope R.S. Glycogen synthase kinase-3β facilitates staurosporine- and heat shock-induced apoptosis. Protection by lithium. Journal of Biological Chemistry. 275:2000;7583-7590.
4. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Analytical Biochemistry. 72:1976;248-254.
5. Brazil D.P., Hemmings B.A. Ten years of protein kinase B signalling: a hard Akt to follow. Trends in Biochemical Sciences. 26:2001;657-664.
6. Brunet A., Datta S.R., Greenberg M.E. Transcription-dependent and -independent control of neuronal survival by the PI3K-Akt signaling pathway. Current Opinion in Neurobiology. 11:2001;297-305.
7. Chalecka-Franaszek E., Chuang D.M. Lithium activates the serine/threonine kinase Akt-1 and suppresses glutamate-induced inhibition of Akt-1 activity in neurons. Proceedings of the National Academy of Sciences of the USA. 96:1999;8745-8750.
8. Chan T.O., Rittenhouse S.E., Tsichlis P.N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annual Review in Biochemistry. 68:1999;965-1014.
9. Chen G., Huang L.D., Jiang Y.M., Manji H.K. The mood-stabilizing agent valproate inhibits the activity of glycogen synthase kinase-3. Journal of Neurochemistry. 72:1999;1327-1330.
10. Cross D.A., Alessi D.R., Cohen P., Andjelkovich M., Hemmings B.A. Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B. Nature. 378:1995;785-789.
11. Crowder R.J., Freeman R.S. Glycogen synthase kinase-3β activity is critical for neuronal death caused by inhibiting phosphatidylinositol 3-kinase or Akt but not for death caused by nerve growth factor withdrawal. Journal of Biological Chemistry. 275:2000;34266-34271.
12. Datta S.R., Brunet A., Greenberg M.E. Cellular survival: a play in three Akts. Genes & Development. 13:1999;2905-2927.
13. Davies S.P., Reddy H., Caivano M., Cohen P. Specificity and mechanism of action of some commonly used protein kinase inhibitors. Biochemical Journal. 351:2000;95-105.
14. Dixon J.F., Hokin L.E. Lithium acutely inhibits and chronically up-regulates and stabilizes glutamate uptake by presynaptic nerve endings in mouse cerebral cortex. Proceedings of the National Academy of Sciences of the USA. 95:1998;8363-8368.
15. Grimes C.A., Jope R.S. The multifaceted roles of glycogen synthase kinase 3β in cellular signaling. Progress in Neurobiology. 65:2001;391-426.
16. Hetman M., Cavanaugh J.E., Kimelman D., Xia Z. Role of glycogen synthase kinase-3β in neuronal apoptosis induced by trophic withdrawal. Journal of Neuroscience. 20:2000;2567-2574.
17. Jope R.S. Anti-bipolar therapy: mechanism of action of lithium. Molecular Psychiatry. 4:1999;117-128.
18. Klein P.S., Melton D.A. A molecular mechanism for the effect of lithium on development. Proceedings of the National Academy of Sciences of the USA. 93:1996;8455-8459.
19. Li X., Bijur G.N., Jope R.S. Glycogen synthase kinase 3β, mood stabilizers, and neuroprotection. Bipolar Disorders. 4:2002;137-144.
20. Marks P.A., Rifkind R.A., Richon V.M., Breslow R. Inhibitors of histone deacetylase are potentially effective anticancer agents. Clinical Cancer Research. 7:2001;759-760.
21. Pap M., Cooper G.M. Role of glycogen synthase kinase-3 in the phosphatidylinositol 3-kinase/Akt cell survival pathway. Journal of Biological Chemistry. 273:1998;19929-19932.
22. Phiel C.J., Zhang F., Huang E.Y., Guenther M.G., Lazar M.A., Klein P.S. Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen. Journal of Biological Chemistry. 276:2001;36734-36741.
23. Ryves W.J., Harwood A.J. Lithium inhibits glycogen synthase kinase-3 by competition for magnesium. Biochemical & Biophysical Research Communications. 280:2001;720-725.
24. Stambolic V., Ruel L., Woodgett J.R. Lithium inhibits glycogen synthase kinase-3 activity and mimics wingless signalling in intact cells. Current Biology. 6:1996;1664-1668.